FDA Inspection
Teva Womens Health, LLCTeva Womens Health, LLC – FDA Inspection, Mar 26, 2025
Record Details
This FDA Inspection record concerns Teva Womens Health, LLC, with an inspection on March 26, 2025, issued by the Cincinnati District Office, covering human drugs.
View Company Profile
ID · 98a97a7b-b464-4612-87d3-51d2e19618a8
Inspection Facts
- Inspection number
- 1265070
- FDA center
- Human Drugs
Other FDA inspections of Teva Womens Health, LLC
12| Date | Classification | Office | Project area |
|---|---|---|---|
| March 20, 2026 | Not classified | Cincinnati District Office | Drug Quality Assurance |
| April 7, 2023 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| January 8, 2020 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 8, 2019 | Not classified | Cincinnati District Office | Generic Drug Evaluation |
| January 26, 2018 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Teva Womens Health, LLC
- FDA Inspection 1308790 - 2026-03-20
- FDA Inspection 1205874 - 2023-04-07
- FDA Inspection 1116385 - 2020-01-08
- FDA Inspection 1078871 - 2019-02-08
- FDA Inspection 1038720 - 2018-01-26
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.